Nesidioblastosis and Mixed Hamartoma of the Liver in Beckwith-Wiedemann Syndrome: Case Study Including Analysis of H19 Methylation and Insulin-like Growth Factor 2 Genotyping and Imprinting
Restricted accessCase reportFirst published online July, 2001
Nesidioblastosis and Mixed Hamartoma of the Liver in Beckwith-Wiedemann Syndrome: Case Study Including Analysis of H19 Methylation and Insulin-like Growth Factor 2 Genotyping and Imprinting
An infant with persistent hyperinsulinemic hypoglycemia, diffuse nesidioblastosis, and mixed hamartoma of the liver (MHL), in addition to demonstrating clinical, pathologic, and molecular manifestations of Beckwith-Wiedemann syndrome (BWS), is the subject of this report. H19 methylation assay and allelic expression analysis for insulin-like growth factor 2 (IGF2) indicated that the patient was mosaic for paternal isodisomic cells and normal cells in lung tissue, nontumoral liver tissue, tissue from the MHL, and pancreatic tissue. We propose that abundant IGF2 expression during development due to paternal isodisomy resulted in hepatomegaly and islet cell hyperplasia, which led to nesidioblastosis. MHL, by contrast, may have resulted from a decrease in disomic cells, compared with nontumoral liver tissue, which showed an increase in disomic cells. Thus, somatic mosaicism may result in unbalanced tissue growth, which may contribute to the formation of MHL in BWS.
Sotelo-AvilaC, Gonzalez-CrussiF, FowlerJ.Complete and imcomplete forms of Beckwith-Wiedemann syndrome: their oncogenic potential. Pediatr1980;96:47–50.
2.
CohenM.A comprehensive and critical assessment of overgrowth and overgrowth syndrome. Adv Hum Genet1989;18:209–212.
3.
SchneidH, SeurinD, VazquezM, GourmelenM, CabrolS, Le BoucY.Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann syndrome. J Med Genet1993;30:353–362.
4.
SchneidH, VazquezM, SeurinD, BoucY.Loss of heterozygosity in non-tumoral tissue in two children with Beckwith-Wiedemann syndrome. Growth Regul1991;1:168–170.
5.
HenryI, PuechA, RiesewijkA, Somatic mosaicism for partial paternal isodisomy in Wiedemann-Beckwith syndrome; a post-fertilization event. Eur J Hum Genet1993;1:19–29.
6.
CatchpooleD, LamW, VallerD, Epigenetic modification and uniparental inheritance of H19 in Beckwith-Wiedemann syndrome. J Med Genet1997;34:353–359.
7.
SlatterR, ElliotM, WelhamK, Mosaic uniparental disomy in Beckwith-Wiedemann syndrome. J Med Genet1994;31:749–753.
8.
ReikW, BrownK, SlatterR, SatoriP, ElliotM, MaherE.Allelic methylation of H19 and IGF2 in the Beckwith-Wiedemann syndrome. Hum Mol Genet1994;3:1297–1301.
9.
SlociaE, CapellaC, KloppelG.Tumor-like lesions of the endocrine pancreas. In: RosaiJ, LHS, eds. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology, 1997:237–246.
10.
RhodesR, MarchildonM, LuebkeD, EdmondsonH, MikityV.A mixed hamartoma of the liver: light and electron microscopy. Hum Pathol1978;9:211–221.
11.
GoossensA, GeptsW, SaundubrayJ.Diffuse and focal nesidioblastosis. A clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. Am J Surg Pathol1989;13:766–775.
12.
MorisonI, BecroftD, TaniguchiT, WoodsC, ReeveAE. Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nat Med1996;2:311–316.
13.
FukuzawaR, UmezawaA, OchiK, IkedaH, HataJ-I.High frequency of inactivation of the imprinted H19 gene in “sporadic” hepatoblastoma. Int J Cancer1999;82:490–497.
14.
SteenmanM, RainierS, DobryC, GrundyP, HoronI, FeinbergA.Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor. Nat Genet1994;7:433–439.
15.
ReikW, BrownK, SchneidH, BoucY, BickmoreW, MaherE.Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by an altered imprinting pattern in the IGF2-H19 domain. Hum Mol Genet1995;4:2379–2385.
16.
HedborgF, HolmgrenL, SandstedtB, OhlssonR.The cell type–specific IGF2 expression during early human development correlates to pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome. Am J Pathol1994; 145:802–817.
17.
OgawaO, BecroftD, MorisinI, Constitutional relaxation of insulin-like growth factor II gene imprinting association with Wilm's tumor and gigantism. Nat Genet1993;5:408–412.
18.
WeksbergR, ShenD, FeiY, SongQ, SquireJ.Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet1993;5:143–150.
19.
MoultonT, CrenshawT, HaoY, Epigenetic lesions at the H19 locus in Wilms' tumor patients. Nat Genet1994; 7:440–447.
20.
ChaoL, HuffV, TomlinsonG, RiccardV, StrongL, SaundersG.Genetic mosaicism in normal tissue of Wilms' tumour patients. 1993;3:127–131.
21.
De LonlayP, FournetJ-C, RahierJ, Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest1997;100:802–807.
22.
VerarreV, FournetJ-C, De LonlayP, Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of imprinted 11p15 imprinted gene lead to persistent hyperinsulinism in focal adenomatous. J Clin Invest1998;102:1286–1291.
23.
TodaT, YamadaM, NakamaB, YamazatoM, HokamaA, MutoY.Immunohistochmical and electron microscopic findings in a case of mixed hamartoma of the liver. Jpn J Surg1990;20:101–106.
24.
ArthurC.Primary hepatic tumor in children. In: FingoldM, ed. Pathology of Neoplasia in Children and Adolescents. PhiladelphiaWB Saunders, 1986:352–354.
25.
OkamotoK, MorisonI, TaniguchiT, ReeveAE. Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis. Proc Natl Acad Sci USA1997;94:5367–5371.
26.
EkströmTJ, CuiH, LiX, OhlssonR.Promoter-specific IGF2 imprinting status and its plasticity during human liver development. Development1995;121:309–316.
